The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression

Renal Failure

Volumn 30, Issue 8, 2008, Pages 763-771

  Wang, Lijun ^a   Zhang, Ligong ^a   Yu, Yonghui ^a   Wang, Yi ^a   Niu, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Intercellular adhesion molecule 1; Lectin like oxidized low density lipoprotein receptor 1; Oxidative stress; Taurine

Indexed keywords

CREATININE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; STREPTOZOCIN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; INTERCELLULAR ADHESION MOLECULE-1; MALE; RATS; RATS, WISTAR; SCAVENGER RECEPTORS, CLASS E; STREPTOZOCIN; TAURINE;

EID: 51849147509     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802272563     Document Type: Article

References (42)

1. Bryla J, Kiersztan A, Jagielski AK. Promising novel approaches to diabetes mellitus therapy: Pharmacological, molecular and cellular insights. Eur Citiz Qual Life. 2003;1:137-161.
2. Ha H, Kim KH. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C. Diabetes Res Clin Prac. 1999;45:147-151.
3. Ujihara N, Sakka Y, Takeda M, Hirayama M, Ishii A, Tomonaga O, Babazono T, et al. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Diabetes Res Clin Pract. 2002;58:109-114.
4. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: Implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther. 2002;95:89-100.
5. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275:12633-12638.
6. Guijarro C, Egido J. Transcription factor-kappa B (NF-kappaB) and renal disease. Kidney Int. 2001;59:415-424.
7. Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant. 2003;18:265-272.
8. Wu Y, Wu G, Qi X, Lin H, Qian H, Shen J, et al. Protein kinase C β inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats. J Pharmacol Sci. 2006;101:335-343.
9. Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, et al. Expression of LOX-1, an oxidized lowdensity lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J Am Soc Nephrol. 2000;11:1826-1836.
10. Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. FASEB J. 2003;17:636-643.
11. Wilson SH, Chade AR, Feldstein A, Sawamura T, Napoli C, Lerman A, et al. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transplant. 2003;18:703-709.
12. Ueno T, Kaname S, Takaichi K, Nagase M, Tojo A, Onozato ML, et al. LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res. 2003;26:117-122.
13. Reichard P, Neilsson BY, Roseuqvist U. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
14. Stackhous S, Miller PI, Park SK, Mever TWL. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes. 1990;39: 985-995.
15. Winiarska K, Fraczyk T, Malinska D, Drozak J, Bryla J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res. 2006;40:168-176.
16. Chang JW, Lee EK, Kim TH, Min WK, Chun S, Lee KU, et al. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: A pilot study. Am J Nephrol. 2007;27:70-74.
17. Egan BM, Abdih H, Kelly CJ, Condron C, Bouchier-Hayes DJ. Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur J Surg. 2001;167:575-580.
18. Sener G, Sehirli O, Ipci Y, Cetine S, Cikler E, Gedik N, et al. Protective effects of taurine against nicotine- induced oxidatvie damage of rat urinary bladder and kidney. Pharmacology. 2005;74:37-44.
19. Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N, Demirogullari B, et al. The effect of taurine on renal ischemia-reperfusion injury. Amino Acids. 2007;32:405-411.
20. Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression. Cardiovascular Drugs and Therapy. 2005;18:105-112.
21. Li F, Abatan OI, Kim H, Burnett D, Larkin D, Obrosova IG, et al. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiology of Disease. 2006;22:669-676.
22. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab. 1999;84:3212-3216.
23. de Castro SH, Castro-Faria-Neto HC, Gomes MB. Association of postprandial hyperglycemia with vitro LDL oxidative in no-smoking patients with Type 1 diabetes - a cross-sectional study. Rev Diabet Stud. 2005;2:157-164.
24. Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, Sawamura T, et al. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: Possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun. 2001;287:962-968.
25. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003;52:2586-2593.
26. Anwar MM, Meki AR. Oxidative stress in streptozotocin-induced diabetic rats: Effects of garlic oil and melatonin. Comparative Biochemistry and Physiology, Part A. 2003;135:539-547.
27. Zanardo RC, Costa Cruz JW, Oliveira MA, Fortes ZB. Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes. Eur J Pharmacol. 2003;478:211-219.
28. Zanardo RC, Costa Cruz JW, Oliveira MA, Fortes ZB. Ascorbic acid supplementation restores defective leukocyte-endothelial interaction in alloxan-diabetic rats. Diabetes Metab Res Rev. 2003;19:60-68.
29. Dhein S, Kabat A, Olbrich A, Rosen P, Schroder H, Mohr FW. Effect of chronic treatment with vitamin E on endothelial dysfunction in a type I in vivo diabetes mellitus model and in vitro. J Pharmacol Exp Ther. 2003;305:114-122.
30. Tenner TE Jr, Zhang XJ, Lombardini JB. Hypoglycemic effects of taurine in the alloxan- treated rabbit: A model for type 1 diabetes. Adv Exp Med Biol. 2003;526:97-104.
31. Casey RG, Gang C, Joyce M, Bouchier-Hayes DJ. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res. 2007;443:1-9.
32. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis. 2002;163:79-87.
33. Tabassum H, Parvez S, Rehman H, Dev Banerjee B, Siemen D, Raisuddin S. Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. Human & Experimental Toxicology. 2007;26:509-518.
34. Chiba Y, Ando K, Fujita T. The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. J Hypertens. 2002;20:2269-2274.
35. Li D, Williams V, Liu L, Chen H, Sawamura T, Antakli T, et al. LOX-1 inhibition in myocardial ischemia-reperfusion injury: Modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol. 2002;283:H1975-H1801.
36. Muscoli C, Sacco I, Alecce W, Palma E, Nistico R, Costa N, et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: Role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther. 2004;311:44-50.
37. Li L, Sawamura T, Renier G. Glucose enhances endothelial LOX-1 expression role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes. 2003;52:1843-1850.
38. Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: Role of LOX-1. J Pharmacol Exp Ther. 2002;302:601-605.
39. Mehta JL, Hu B, Chen J, Li D. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol. 2003;23:2203-2208.
40. Ouslimani N, Mahrouf M, Peynet J, Bonnefont-Rousselot D, Cosson C, et al. Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1. Metabolism Clinical and Experimental. 2007;56:308-313.
41. Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: Glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes. 1997;46:2075-2081.
42. Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K, et al. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCε-MAPK-p90RSK, and rho-kinase pathway. Hypertension. 2005;45:538-544.